Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07212361 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Infant Microbiota Restoration With Maternal Microbes

Study acronym: MaMi
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
The goal of this clinical trial is to test the ability of different bacterial products in restoring natural gut microbiota in C-section born infants. The main question it aims to answer is: Do maternally derived strains of bacteria perform better than commercially available probiotic strains in restoring the gut microbiota of C-section born infants? Researchers will compare the gut microbiota of treated infants to that of untreated C-section born infants and untreated vaginally born infants to see if the bacterial treatments cause the microbiota to resemble that of vaginally born infants. Participants will be given a bacterial product orally once daily for either one or four weeks and be asked to collect faecal, urine and saliva samples.
Trial Details
NCT Number NCT07212361
Lead Sponsor University of Helsinki
Collaborators: Helsinki University Central Hospital
Conditions
(from sponsor)		 Infant, Newborn, Gut -Microbiota, Gut Dysbiosis, Cesarean Delivery Affecting Newborn, Cesarean Section, Vaginal Delivery, Gastrointestinal Microbiota, Microbiota, Cesarean Section, Probiotics, Dysbiosis +7 more
Related terms Dysbiosis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov